NCT02420691 2020-10-30Ribociclib in Treating Patients With Advanced Neuroendocrine Tumors of Foregut OriginM.D. Anderson Cancer CenterPhase 2 Completed21 enrolled 14 charts
NCT02364076 2019-12-13Pembrolizumab and Epacadostat in Patients With Thymic CarcinomaGeorgetown UniversityPhase 2 Unknown45 enrolled 10 charts
NCT01364727 2019-04-16A Phase 2 Study of Amrubicin in Relapsed or Refractory Thymic MalignanciesStanford UniversityPhase 2 Completed33 enrolled 11 charts